SCHEMBL16229241

SCHEMBL16229241

C=C(OCC)c1c(C2CCC(OCCOC)(C(=O)OCCOC)CC2)nc2c(-c3ccc(C4=NC=CC4)nc3)cnn2c1N(COCC[Si](C)(C)C)COCC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15031516 0.96 DGAT1 (0.30) —
SCHEMBL15031517 0.95 — —
SCHEMBL15031515 0.93 — —
SCHEMBL16229239 0.90 — —
SCHEMBL15007519 0.89 DGAT1 (0.31) —
SCHEMBL15026301 0.89 DGAT1 (0.31) —
SCHEMBL15007135 0.89 DGAT1 (0.31) —
SCHEMBL15007384 0.89 DGAT1 (0.33) —
SCHEMBL15007268 0.84 DGAT1 (0.34) —
SCHEMBL16222844 0.84 DGAT1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883801-B2 Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2014-11-11 — — US disclosed
Send feedback